0001628280-24-020920 | 6-K | XBRL Viewer

Unaudited Interim Condensed Consolidated Statements of Comprehensive Income (Loss) - EUR (€) € in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Statement of comprehensive income [abstract]
PROFIT/(LOSS) FOR THE PERIOD	€ 58,909	€ (18,127)
Items that may be reclassified to profit or loss
Currency translation differences	(57)	1,628
Other comprehensive income/(loss) for the period, net of tax	(57)	1,628
TOTAL COMPREHENSIVE INCOME/(LOSS) FOR THE PERIOD	€ 58,853	€ (16,500)

- Definition

The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 18
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_18_b&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 1
-IssueDate 2023-01-01
-Paragraph 32
-Subparagraph a
-Clause ii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_32_a_ii&doctype=Standard
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 1
-IssueDate 2023-01-01
-Paragraph 24
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_24_b&doctype=Standard
-URIDate 2023-03-23

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2023-01-01
-Paragraph 28
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_b&doctype=Standard
-URIDate 2023-03-23

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2023-01-01
-Paragraph 23
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23&doctype=Standard
-URIDate 2023-03-23

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Name IFRS
-Number 12
-IssueDate 2023-01-01
-Paragraph B10
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B
-URIDate 2023-03-23

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Name IFRS
-Number 17
-IssueDate 2023-01-01
-Paragraph 113
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_113_b&doctype=Standard
-URIDate 2023-03-23

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 81A
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81A_a&doctype=Standard
-URIDate 2023-03-23

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 106
-Subparagraph d
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d_i&doctype=Standard
-URIDate 2023-03-23

+ Details

Unaudited Interim Condensed Consolidated Statements of Income (Loss) - EUR (€) € in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Profit or loss [abstract]
Product sales	€ 32,149	€ 32,100
Other revenues	604	1,408
REVENUES	32,753	33,508
Cost of goods and services	(22,160)	(20,480)
Research and development expenses	(13,131)	(14,065)
Marketing and distribution expenses	(11,333)	(8,986)
General and administrative expenses	(11,670)	(10,038)
Gain from sale of Priority Review Voucher, net	90,833	0
Other income and expenses, net	2,917	3,488
OPERATING PROFIT/(LOSS)	68,208	(16,574)
Finance income	266	253
Finance expenses	(7,045)	(5,096)
Foreign exchange gain/(loss), net	(2,512)	3,170
PROFIT/(LOSS) BEFORE INCOME TAX	58,918	(18,247)
Income tax benefit/(expense)	(8)	120
PROFIT/(LOSS) FOR THE PERIOD	€ 58,909	€ (18,127)
Earnings/(losses) per share for profit/(loss) for the period attributable to the equity holders of the Company (expressed in € per share)
Basic earnings (losses) per share for profit/(loss) for the period attributable to the equity holders of the Company (in euro per share)	€ 0.42	€ (0.13)
Diluted earnings (losses) per share for profit/(loss) for the period attributable to the equity holders of the Company (in euro per share)	€ 0.41	€ (0.13)

Unaudited Interim Condensed Consolidated Statement of Financial Position - EUR (€) € in Thousands	Mar. 31, 2024	Dec. 31, 2023
ASSETS
Non-current assets	€ 196,588	€ 197,238
Intangible assets	24,853	25,567
Right of use assets	19,267	20,392
Property, plant and equipment	136,696	136,198
Deferred tax assets	7,006	6,592
Other non-current assets	8,766	8,490
Current assets	306,241	262,824
Inventories	48,585	44,466
Trade receivables	27,285	41,645
Other current assets	53,732	50,633
Cash and cash equivalents	176,640	126,080
TOTAL ASSETS	502,829	460,062
EQUITY
Share capital	20,892	20,837
Share premium	593,948	594,003
Other reserves	67,162	65,088
Retained earnings/(Accumulated deficit)	(551,682)	(450,253)
Profit/(Loss) for the period	58,909	(101,429)
TOTAL EQUITY	189,230	128,247
LIABILITIES
Non-current liabilities	197,515	172,952
Borrowings	159,035	132,768
Lease liabilities	27,547	29,090
Refund liabilities	6,350	6,303
Provisions	810	1,074
Deferred tax liabilities	3,704	3,638
Other liabilities	70	79
Current liabilities	116,085	158,863
Borrowings	22,413	44,079
Trade payables and accruals	33,506	44,303
Income tax liability	746	632
Tax and Employee-related liabilities	17,271	16,209
Lease liabilities	2,676	2,879
Contract liabilities	5,291	5,697
Refund liabilities	24,258	33,637
Provisions	9,553	10,835
Other liabilities	371	592
TOTAL LIABILITIES	313,600	331,815
TOTAL EQUITY AND LIABILITIES	€ 502,829	€ 460,062

Unaudited Interim Condensed Consolidated Statement of Changes in Equity - EUR (€) € in Thousands	Total	Share capital	Share premium	Other reserves	Retained earnings/ (Accumulated deficit)	Profit/(loss) for the period
Equity, beginning balance at Dec. 31, 2022	€ 219,797	€ 20,755	€ 594,043	€ 55,252	€ (306,974)	€ (143,279)
Total comprehensive income/(loss)	(16,500)			1,628		(18,127)
Income appropriation	0				(143,279)	143,279
Share-based compensation expense:
Value of services	1,489			1,489
Exercises	(3)	(3)
Equity, ending balance at Mar. 31, 2023	204,783	20,752	594,043	58,369	(450,253)	(18,127)
Equity, beginning balance at Dec. 31, 2023	128,247	20,837	594,003	65,088	(450,253)	(101,429)
Total comprehensive income/(loss)	58,853			(57)		58,909
Income appropriation	0				(101,429)	101,429
Share-based compensation expense:
Value of services	2,130			2,130
Exercises	0	55	(55)
Equity, ending balance at Mar. 31, 2024	€ 189,230	€ 20,892	€ 593,948	€ 67,162	€ (551,682)	€ 58,909

- Definition

The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners.

+ References + Details

- Definition

The amount of residual interest in the assets of the entity after deducting all its liabilities.

+ References + Details

Unaudited Interim Condensed Consolidated Statement of Cash Flows - EUR (€) € in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES
Profit/(Loss) for the period	€ 58,909	€ (18,127)
Gain from sale of Priority Review Voucher, net	(90,833)	0
Adjustments for non-cash transactions	15,072	8,438
Changes in non-current operating assets and liabilities	(529)	(269)
Changes in working capital	(10,923)	(13,935)
Cash generated/(used) in operations	(28,303)	(23,893)
Income tax paid	(129)	(433)
NET CASH GENERATED FROM/(USED IN) OPERATING ACTIVITIES	(28,432)	(24,326)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchases of property, plant and equipment	(4,498)	(3,846)
Proceeds from sale of property, plant and equipment	146	33
Purchases of intangible assets	(34)	0
Proceeds from sale of Priority Review Voucher	90,833	0
Interest received	266	253
NET CASH GENERATED FROM/(USED IN) INVESTING ACTIVITIES	86,713	(3,561)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds/(payments) from issuance of common stock, net of costs of equity transactions	0	(194)
Proceeds from borrowings, net of transaction costs	(944)	0
Payment of lease liabilities	(677)	(933)
Interest paid	(5,836)	(2,689)
NET CASH GENERATED FROM/(USED IN) FINANCING ACTIVITIES	(7,457)	(3,816)
NET CHANGE IN CASH AND CASH EQUIVALENTS	50,824	(31,703)
Cash and cash equivalents at beginning of the year	126,080	286,532
Exchange gains/(losses) on cash	(264)	(344)
CASH AND CASH EQUIVALENTS AT END OF THE PERIOD	€ 176,640	€ 254,485

Cover	3 Months Ended
Cover	Mar. 31, 2024
Cover [Abstract]
Document Type	6-K
Entity Registrant Name	VALNEVA SE
Entity Central Index Key	0001836564
Amendment Flag	false
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q1
Current Fiscal Year End Date	--12-31
Document Period End Date	Mar. 31, 2024

Print Document
Reports Cover Statements Unaudited Interim Condensed Consolidated Statements of Income (Loss) Unaudited Interim Condensed Consolidated Statements of Comprehensive Income (Loss) Unaudited Interim Condensed Consolidated Statement of Financial Position Unaudited Interim Condensed Consolidated Statement of Cash Flows Unaudited Interim Condensed Consolidated Statement of Changes in Equity All Reports